These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 9039718)

  • 21. [Antihypertensive effectiveness and tolerance of cicletanine. Results obtained with bitherapy].
    Tarrade T; Berthet P; Paillasseur JL; Bosquet D; Allard M
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():103-8. PubMed ID: 2575367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
    Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Old or new antihypertensives--which are better?].
    Schrader J; Kulschewski A
    MMW Fortschr Med; 2005 Mar; 147(13):36-7, 39-40. PubMed ID: 15832760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension.
    Morgan TO; Anderson AI; MacInnis RJ
    Am J Hypertens; 2001 Mar; 14(3):241-7. PubMed ID: 11281235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Managing hypertension using combination therapy.
    Frank J
    Am Fam Physician; 2008 May; 77(9):1279-86. PubMed ID: 18540493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
    Ferri C; Croce G; Desideri G
    Adv Ther; 2008 Apr; 25(4):300-20. PubMed ID: 18449492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapeutic strategy in arterial hypertension].
    Waeber B; Nussberger J; Brunner HR
    Schweiz Med Wochenschr; 1987 Feb; 117(7):227-38. PubMed ID: 2882599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination therapy with ACE inhibitors/angiotensin II receptor antagonists and diuretics in hypertension.
    Waeber B
    Expert Rev Cardiovasc Ther; 2003 May; 1(1):43-50. PubMed ID: 15030296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hypertension therapy in practice test. Calcium antagonist receives good marks].
    Keck M; Sauerbrey-Wullkopf N; Regourd E; Clemens A
    MMW Fortschr Med; 2005 Jan; 147(1-2):51. PubMed ID: 15704573
    [No Abstract]   [Full Text] [Related]  

  • 32. Betablockers in combination with other antihypertensives.
    Manjuran RJ
    Indian Heart J; 2010; 62(2):146-7. PubMed ID: 21180307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of hypertension from volume to vasoconstriction: The ACE up your sleeve.
    Stanley JC; Samson RH
    Semin Vasc Surg; 2002 Dec; 15(4):225-36. PubMed ID: 12478497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treating hypertension. Are the right drugs given to the right patients?
    Beaulieu MD; Dufresne L; LeBlanc D
    Can Fam Physician; 1998 Feb; 44():294-8, 301-2. PubMed ID: 9512833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium antagonists-ACE inhibitors combination therapy: objectives and methodology of clinical development.
    Menard J; Bellet M
    J Cardiovasc Pharmacol; 1993; 21 Suppl 2():S49-54. PubMed ID: 7692151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New and emerging drug treatments for hypertension.
    Krum H; Pellizzer AM
    Aust Fam Physician; 1998 Apr; 27(4):235-7, 240-2. PubMed ID: 9581329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term safety of antihypertensive therapy.
    Grossman E; Messerli FH
    Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fixed low-dose combination of an angiotensin converting enzyme inhibitor and a calcium channel blocker drug in the treatment of essential hypertension.
    de Leeuw PW; Kroon AA
    J Hypertens Suppl; 1997 Mar; 15(2):S39-42. PubMed ID: 9218197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination therapy in hypertension.
    Gradman AH; Basile JN; Carter BL; Bakris GL;
    J Am Soc Hypertens; 2010; 4(1):42-50. PubMed ID: 20374950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.